Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38201
CAS Number:
366-70-1
Chlorhydrate de procarbazine
Purity:
≥ 98 % (HPLC)
Synonym(s):
Chlorhydrate de N -isopropyl-4-[(2-méthylhydrazino)méthyl]benzamide
Documents
$115.27 /100 mg
Taille
Request Bulk Quote
Informations sur le produit

Procarbazine hydrochloride is a potent antineoplastic agent primarily utilized in the treatment of certain types of cancer, including Hodgkin's lymphoma and brain tumors. This compound functions as an alkylating agent, disrupting DNA synthesis and cell division, making it effective in targeting rapidly dividing cancer cells. Its unique mechanism of action allows it to be used in combination with other chemotherapeutic agents, enhancing overall treatment efficacy. Researchers and healthcare professionals appreciate its role in multi-drug regimens, as it can improve patient outcomes and reduce the likelihood of drug resistance.

In addition to its therapeutic applications, Procarbazine hydrochloride is also of interest in research settings, where it is studied for its potential effects on various cellular pathways. Its ability to cross the blood-brain barrier makes it particularly valuable in neuro-oncology, where effective treatment options are limited. With a favorable safety profile when monitored correctly, Procarbazine hydrochloride continues to be a vital component in cancer therapy and research, offering hope for improved treatment strategies.

Numéro CAS 
366-70-1
Formule moléculaire
C12H19N3O · HCl
Poids moléculaire 
257.76
Point de fusion 
225 - 227 °C
Informations générales
Numéro CAS 
366-70-1
Formule moléculaire
C12H19N3O · HCl
Poids moléculaire 
257.76
Point de fusion 
225 - 227 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Procarbazine hydrochloride is widely utilized in research focused on

  • Cancer Treatment: Primarily used as a chemotherapy agent, it is effective in treating certain types of cancers, particularly Hodgkin's lymphoma. Its ability to inhibit cell division makes it a crucial part of combination therapy regimens.
  • Research in Oncology: Researchers often use this compound in clinical trials to study its efficacy and safety in various cancer treatments, helping to develop new therapeutic strategies.
  • Pharmaceutical Development: It serves as a model compound in the development of new anti-cancer drugs, allowing scientists to explore modifications that enhance effectiveness or reduce side effects.
  • Mechanistic Studies: Procarbazine hydrochloride is utilized in laboratory settings to understand the biochemical pathways involved in cancer cell proliferation and resistance, providing insights for future therapies.
  • Combination Therapies: Its use in conjunction with other chemotherapeutic agents is studied to improve treatment outcomes, making it a valuable tool in developing multi-drug regimens.

Citations